Polyclonal Rabbit anti‑Human DDAH2 Antibody (Cy3, aa31‑265, WB) LS‑C703866
Polyclonal Rabbit anti‑Human DDAH2 Antibody (Cy3, aa31‑265, WB) LS‑C703866
Antibody:
DDAH2 Rabbit anti-Human Polyclonal (aa31-265) (Cy3) Antibody
Overview
Antibody:
DDAH2 Rabbit anti-Human Polyclonal (aa31-265) (Cy3) Antibody
Specifications
Description
DDAH2 antibody LS-C703866 is a Cy3-conjugated rabbit polyclonal antibody to DDAH2 (aa31-265) from human. It is reactive with human and pig. Validated for WB.
Target
Human DDAH2
Synonyms
DDAH2 | DDAH | DDAH-2 | DDAHII | G6a | Alternative name: NG30, G6a | Unknown | Dimethylargininase-2 | NG30 | Protein G6a | S-phase protein
Reactivity
Human, Pig
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant DDAH2 (Ala31-Leu265) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against DDAH2.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Reactivity:
All species
Range:
24.69-2000 pg/ml
Reactivity:
Rat
Range:
0.312-20 ng/ml
Species:
Human
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024